1,452
Views
12
CrossRef citations to date
0
Altmetric
Review Article

Stress-mediated modulations in dopaminergic system and their subsequent impact on behavioral and oxidative alterations: An update

&
Pages 368-377 | Received 04 Apr 2013, Accepted 20 Aug 2013, Published online: 23 Oct 2013

References

  • Aguilar Hernandez R, Sanchez De Las Matas MJ, Arriagada C, et al. (2003). MPP(+)-induced degeneration is potentiated by dicoumarol in cultures of the RCSN-3 dopaminergic cell line. Implications of neuromelanin in oxidative metabolism of dopamine neurotoxicity. Neurotox Res 5:407–10
  • Ahmad A, Rasheed N, Banu N, Palit G. (2010). Alterations in monoamine levels and oxidative systems in frontal cortex, striatum, and hippocampus of the rat brain during chronic unpredictable stress. Stress 13:355–64
  • Amoroso S, Tortiglione A, Secondo A, et al. (2000). Sodium nitroprusside prevents chemical hypoxia-induced cell death through iron ions stimulating the activity of the Na+-Ca2+ exchanger in C6 glioma cells. J Neurochem 74:1505–13
  • Andersen JK. (2004). Oxidative stress in neurodegeneration: Cause or consequence? Nat Med 10:S18–25
  • Andrews J, Ali N, Pruessner JC. (2013). Reflections on the interaction of psychogenic stress systems in humans: The stress coherence/compensation model. Psychoneuroendocrinology 38:947–61
  • Armario A. (2006). The hypothalamic-pituitary-adrenal axis: What can it tell us about stressors? CNS NeurolDisord Drug Targets 5:485–501.
  • Arnsten AF. (2011). Prefrontal cortical network connections: Key site of vulnerability in stress and schizophrenia. Int J Dev Neurosci 29:215–23
  • Asanuma M, Miyazaki I, Diaz-Corrales FJ, Ogawa N. (2004). Quinone formation as dopaminergic neuron-specific oxidative stress in the pathogenesis of sporadic Parkinson’s disease and neurotoxin-induced parkinsonism. Acta Med Okayama 58:221–33
  • Asanuma M, Miyazaki I, Ogawa N. (2003). Dopamine- or l-DOPA-induced neurotoxicity: The role of dopamine quinone formation and tyrosinase in a model of Parkinson’s disease. Neurotox Res 53:165–76
  • Bedard C, Wallman MJ, Pourcher E, et al. (2011). Serotonin and dopamine striatal innervations in Parkinson’s disease and Huntington’s chorea. Parkinsonism Relat Disord 17:593–8
  • Bekris S, Antoniou K, Daskas S, Papadopoulou-Daifoti Z. (2005). Behavioural and neurochemical effects induced by chronic mild stress applied to two different rat strains. Behav Brain Res 161:45–59
  • Benskey M, Behrouz B, Sunryd J, et al. (2012). Recovery of hypothalamic tuberoinfundibular dopamine neurons from acute toxicant exposure is dependent upon protein synthesis and associated with an increase in parkin and ubiquitin carboxy-terminal hydrolase-L1 expression. Neurotoxicology 33:321–31
  • Benturquia N, Courtin C, Noble F, Marie-Claire C. (2008). Involvement of D1 dopamine receptor in MDMA-induced locomotor activity and striatal gene expression in mice. Brain Res 1211:1–5
  • Berridge KC. (2007). The debate over dopamine’s role in reward: The case for incentive salience. Psychopharmacology (Berl) 191:391–431
  • Bilici M, Efe H, Koroglu MA, et al. (2001). Antioxidative enzyme activities and lipid peroxidation in major depression: Alterations by antidepressant treatments. J Affect Disord 64:43–51
  • Bozzi Y, Vallone D, Borrelli E. (2000). Neuroprotective role of dopamine against hippocampal cell death. J Neurosci 20:8643–9
  • Bozzi Y, Borrelli E. (2006). Dopamine in neurotoxicity and neuroprotection: What do D2 receptors have to do with it? Trends Neurosci 29:167–74.
  • Bressan RA, Crippa JA. (2005). The role of dopamine in reward and pleasure behaviour – Review of data from preclinical research. Acta Psychiatr Scand Suppl 427:14–21
  • Brooks AM, Berns GS. (2013). Aversive stimuli and loss in the mesocorticolimbic dopamine system. Trends Cogn Sci 17:281–6
  • Cabib S, Puglisi-Allegra S. (1996). Stress, depression and the mesolimbic dopamine system. Psychopharmacology (Berl) 128:331–42
  • Cabib S, Puglisi-Allegra S. (2012). The mesoaccumbens dopamine in coping with stress. Neurosci Biobehav Rev 36:79–89
  • Capper-Loup C, Canales JJ, Kadaba N, Graybiel AM. (2002). Concurrent activation of dopamine D1 and D2 receptors is required to evoke neural and behavioral phenotypes of cocaine sensitization. J Neurosci 22:6218–27
  • Carpagnano GE, Kharitonov SA, Resta O, et al. (2003). 8-Isoprostane, a marker of oxidative stress, is increased in exhaled breath condensate of patients with obstructive sleep apnea after night and is reduced by continuous positive airway pressure therapy. Chest 124:1386–92
  • Carrasco GA, Van de Kar LD. (2003). Neuroendocrine pharmacology of stress. Eur J Pharmacol 463:235–72
  • Charntikov S, Der-Ghazarian T, Herbert MS, et al. (2011). Importance of D1 and D2 receptors in the dorsal caudate-putamen for the locomotor activity and stereotyped behaviors of preweanling rats. Neuroscience 183:121–33
  • Choi HJ, Lee SY, Cho Y, Hwang O. (2005). Inhibition of vesicular monoamine transporter enhances vulnerability of dopaminergic cells: Relevance to Parkinson’s disease. Neurochem Int 464:329–35
  • Cregan SP, Fortin A, MacLaurin JG, et al. (2002). Apoptosis-inducing factor is involved in the regulation of caspase-independent neuronal cell death. J Cell Biol 158:507–17
  • Cyr M, Morissette M, Barden N, et al. (2001). Dopaminergic activity in transgenic mice underexpressing glucocorticoid receptors: Effect of antidepressants. Neuroscience 102:151–8
  • De Deyn PP, Drenth AF, Kremer BP, et al. (2013). Aripiprazole in the treatment of Alzheimer’s disease. Expert Opin Pharmacother 14:459–74
  • de Jong IE, de Kloet ER. (2004). Glucocorticoids and vulnerability to psychostimulant drugs: Toward substrate and mechanism. Ann N Y Acad Sci 1018:192–8
  • del Rosario CN, Pacchioni AM, Cancela LM. (2002). Influence of acute or repeated restraint stress on morphine-induced locomotion: Involvement of dopamine, opioid and glutamate receptors. Behav Brain Res 134:229–38
  • Espana RA, Jones SR. (2013). Presynaptic dopamine modulation by stimulant self-administration. Front Biosci 5:261–76
  • Floresco SB, Magyar O. (2006). Mesocortical dopamine modulation of executive functions: Beyond working memory. Psychopharmacology (Berl) 188:567–85
  • Floresco SB. (2007). Dopaminergic regulation of limbic-striatal interplay. J Psychiatry Neurosci 326:400–11
  • Galistu A, Daquila PS. (2013). Dopamine on D2-like receptors “reboosts” dopamine D1-like receptor-mediated behavioural activation in rats licking for a isotonic NaCl solution. Psychopharmacology (Berl) 229:357–66
  • Gandhi S, Vaarmann A, Yao Z, et al. (2012). Dopamine induced neurodegeneration in a PINK1 model of Parkinson’s disease. PLoS One 7:e37564
  • Goeders NE. (2002). The HPA axis and cocaine reinforcement. Psychoneuroendocrinology 27:13–33
  • Granon S, Passetti F, Thomas KL, et al. (2000). Enhanced and impaired attentional performance after infusion of D1 dopaminergic receptor agents into rat prefrontal cortex. J Neurosci 203:1208–15
  • Grima G, Benz B, Parpura V, et al. (2003). Dopamine-induced oxidative stress in neurons with glutathione deficit: Implication for schizophrenia. Schizophr Res 62:213–24
  • Haghparast A, Esmaeili MH, Taslimi Z, et al. (2013). Intrahippocampal administration of D2 but not D1 dopamine receptor antagonist suppresses the expression of conditioned place preference induced by morphine in the ventral tegmental area. Neurosci Lett 541:138–43
  • Harro J, Oreland L. (2001). Depression as a spreading adjustment disorder of monoaminergic neurons: A case for primary implication of the locus coeruleus. Brain Res Brain Res Rev 38:79–128
  • Hermida-Ameijeiras A, Mendez-Alvarez E, Sanchez-Iglesias S, et al. (2004). Autoxidation and MAO-mediated metabolism of dopamine as a potential cause of oxidative stress: Role of ferrous and ferric ions. Neurochem Int 45:103–16
  • Hirano S, Shinotoh H, Eidelberg D. (2012). Functional brain imaging of cognitive dysfunction in Parkinson’s disease. J Neurol Neurosurg Psychiatry 83:963–9
  • Ho HY, Cheng ML, Shiao MS, Chiu DT. (2013). Characterization of global metabolic responses of glucose-6-phosphate dehydrogenase-deficient hepatoma cells to diamide-induced oxidative stress. Free Radic Biol Med 54:71–84
  • Ikemoto S. (2007). Dopamine reward circuitry: Two projection systems from the ventral midbrain to the nucleus accumbens-olfactory tubercle complex. Brain Res Rev 561:27–78
  • Isacson R, Kull B, Wahlestedt C, Salmi P. (2004). A 68930 and dihydrexidine inhibit locomotor activity and d-amphetamine-induced hyperactivity in rats: A role of inhibitory dopamine D (1/5) receptors in the prefrontal cortex? Neuroscience 1241:33–42.
  • Jahng JW, Ryu V, Yoo SB, et al. (2010). Mesolimbic dopaminergic activity responding to acute stress is blunted in adolescent rats that experienced neonatal maternal separation. Neuroscience 171:144–52
  • Jankord R, Herman JP. (2008). Limbic regulation of hypothalamo-pituitary-adrenocortical function during acute and chronic stress. Ann N Y Acad Sci 1148:64–73
  • Joels M, Karst H, Krugers HJ, Lucassen PJ. (2007). Chronic stress: Implications for neuronal morphology, function and neurogenesis. Front Neuroendocrinol 28:72–96
  • Joels M, Pu Z, Wiegert O, et al. (2006). Learning under stress: How does it work? Trends Cogn Sci 10:152–8.
  • Kalia M. (2005). Neurobiological basis of depression: An update. Metabolism 54:24–7
  • Kambarova DK, Golubev AG. (2011). Biochemical and genetic aspects of pathogenesis of schizophrenia. Zh Evol Biokhim Fiziol 47:348–57
  • Klimek V, Schenck JE, Han H, et al. (2002). Dopaminergic abnormalities in amygdaloid nuclei in major depression: A postmortem study. Biol Psychiatry 52:740–8
  • LaHoste GJ, Henry BL, Marshall JF. (2000). Dopamine D1 receptors synergize with D2, but not D3 or D4, receptors in the striatum without the involvement of action potentials. J Neurosci 20:6666–71
  • Lev N, Barhum Y, Pilosof NS, et al. (2013). DJ-1 protects against dopamine toxicity: Implications for Parkinson’s disease and aging. J Gerontol A Biol Sci Med Sci 68:215–25
  • Lex A, Hauber W. (2008). Dopamine D1 and D2 receptors in the nucleus accumbens core and shell mediate Pavlovian-instrumental transfer. Learn Mem 15:483–91
  • Li R, Strykowski R, Meyer M, et al. (2012). Male-specific differences in proliferation, neurogenesis, and sensitivity to oxidative stress in neural progenitor cells derived from a rat model of ALS. PLoS One 7:e48581
  • Lucas LR, Celen Z, Tamashiro KL, et al. (2004). Repeated exposure to social stress has long-term effects on indirect markers of dopaminergic activity in brain regions associated with motivated behavior. Neuroscience 124:449–57
  • Lucca G, Comim CM, Valvassori SS, et al. (2009). Effects of chronic mild stress on the oxidative parameters in the rat brain. Neurochem Int 54:358–62
  • Madras BK, Miller GM, Fischman AJ. (2005). The dopamine transporter and attention-deficit/hyperactivity disorder. Biol Psychiatry 57:1397–409
  • Mansour A, Meador-Woodruff JH, Bunzow JR, et al. (1990). Localization of dopamine D2 receptor mRNA and D1 and D2 receptor binding in the rat brain and pituitary: An in situ hybridization-receptor autoradiographic analysis. J Neurosci 10:2587–600
  • McEwen BS. (2000). The neurobiology of stress: From serendipity to clinical relevance. Brain Res 886:172–89
  • Metodiewa D, Koska C. (2000). Reactive oxygen species and reactive nitrogen species: Relevance to cyto(neuro)toxic events and neurologic disorders. An overview. Neurotox Res 1:197–233
  • Miyazaki I, Asanuma M. (2008). Dopaminergic neuron-specific oxidative stress caused by dopamine itself. Acta Med Okayama 62:141–50
  • Mizoguchi K, Yuzurihara M, Ishige A, et al. (2000). Chronic stress induces impairment of spatial working memory because of prefrontal dopaminergic dysfunction. J Neurosci 20:1568–74
  • MohanKumar SM, Kasturi BS, Shin AC, et al. (2011). Chronic estradiol exposure induces oxidative stress in the hypothalamus to decrease hypothalamic dopamine and cause hyperprolactinemia. Am J Physiol Regul Integr Comp Physiol 300:R693–9
  • Moore H, Rose HJ, Grace AA. (2001). Chronic cold stress reduces the spontaneous activity of ventral tegmental dopamine neurons. Neuropsychopharmacology 24:410–19
  • Mora F, Segovia G, Del Arco A, et al. (2012). Stress, neurotransmitters, corticosterone and body-brain integration. Brain Res 1476:71–85
  • Nadal R. (2001). Pharmacology of the atypical antipsychotic remoxipride, a dopamine D2 receptor antagonist. CNS Drug Rev 7:265–82
  • Neve KA, Seamans JK, Trantham-Davidson H. (2004). Dopamine receptor signaling. J Recept Signal Transduct Res 24:165–205
  • Nieullon A, Coquerel A. (2003). Dopamine: A key regulator to adapt action, emotion, motivation and cognition. Curr Opin Neurol 16:S3–9
  • Nikiforuk A. (2013). Quetiapine ameliorates stress-induced cognitive inflexibility in rats. Neuropharmacology 64:357–64
  • Noori HR, Spanagel R, Hansson AC. (2012). Neurocircuitry for modeling drug effects. Addict Biol 17:827–64
  • Obara I, Goulding SP, Gould AT, et al. (2013). Homers at the Interface between Reward and Pain. Front Psychiatry 4:39 (1--12)
  • Pania L, Gessab GL. (2002). Dopaminergic deficit and mood disorders. Int Clin Psychopharmacol 17:S1–7
  • Park SK, Nguyen MD, Fischer A, et al. (2005). Par-4 links dopamine signaling and depression. Cell 122:275–87
  • Perez-Nievas BG, Garcia-Bueno B, Caso JR, et al. (2007). Corticosterone as a marker of susceptibility to oxidative/nitrosative cerebral damage after stress exposure in rats. Psychoneuroendocrinology 32:703–11
  • Rasheed N, Ahmad A, Pandey CP, et al. (2010a). Differential response of central dopaminergic system in acute and chronic unpredictable stress models in rats. Neurochem Res 351:22–32
  • Rasheed N, Ahmad A, Singh N, et al. (2010b). Differential response of A 68930 and sulpiride in stress-induced gastric ulcers in rats. Eur J Pharmacol 643:121–8
  • Rasheed N, Ahmad A, Al-Sheeha M, et al. (2011). Neuroprotective and anti-stress effect of A68930 in acute and chronic unpredictable stress model in rats. Neurosci Lett 504:151–5
  • Rasheed N, Alghasham A. (2012). Central dopaminergic system and its implications in stress-mediated neurological disorders and gastric ulcers: Short review. Adv Pharmacol Sci 2012:182671 (1--11)
  • Rezvani AH, Eddins D, Slade S, et al. (2008). Neonatal 6-hydroxydopamine lesions of the frontal cortex in rats: Persisting effects on locomotor activity, learning and nicotine self-administration. Neuroscience 1543:885–97
  • Rudzinska M, Szczudlik A. (2007). Apomorphine in off state clinical experience. Neurol Neurochir Pol 41:S40–8
  • Salamone JD, Correa M, Mingote SM, Weber SM. (2005). Beyond the reward hypothesis: Alternative functions of nucleus accumbens dopamine. Curr Opin Pharmacol 5:34–41
  • Sapolsky RM. (2000). The possibility of neurotoxicity in the hippocampus in major depression: A primer on neuron death. Biol Psychiatry 48:755–65
  • Schiavone S, Jaquet V, Trabace L, Krause KH. (2013). Severe life stress and oxidative stress in the brain: From animal models to human pathology. Antioxid Redox Signal 18:1475–90
  • Shen LH, Liao MH, Tseng YC. (2012). Recent advances in imaging of dopaminergic neurons for evaluation of neuropsychiatric disorders. J Biomed Biotechnol 2012:259349 (1--14)
  • Siraki AG, O’Brien PJ. (2002). Prooxidant activity of free radicals derived from phenol-containing neurotransmitters. Toxicology 177:81–90
  • Smith JW, Fetsko LA, Xu R, Wang Y. (2002). Dopamine D2L receptor knockout mice display deficits in positive and negative reinforcing properties of morphine and in avoidance learning. Neuroscience 113:755–65
  • Smith LK, Jadavji NM, Colwell KL, et al. (2008). Stress accelerates neural degeneration and exaggerates motor symptoms in a rat model of Parkinson’s disease. Eur J Neurosci 27:2133–46
  • Snyder AM, Stricker EM, Zigmond MJ. (1985). Stress-induced neurological impairments in an animal model of parkinsonism. Ann Neurol 18:544–51
  • Sorensen C, Johansen IB, Overli O. (2012). Neural plasticity and stress coping in teleost fishes. Gen Comp Endocrinol 181:25–34
  • Tafet GE, Bernardini R. (2003). Psychoneuroendocrinological links between chronic stress and depression. Prog Neuropsychopharmacol Biol Psychiatry 27:893–903
  • Tofaris GK, Garcia Reitbock P, Humby T, et al. (2006). Pathological changes in dopaminergic nerve cells of the substantia nigra and olfactory bulb in mice transgenic for truncated human alpha-synuclein(1-120): Implications for Lewy body disorders. J Neurosci 26:3942–50
  • Torres RL, Torres IL, Gamaro GD, et al. (2004). Lipid peroxidation and total radical-trapping potential of the lungs of rats submitted to chronic and sub-chronic stress. Braz J Med Biol Res 37:185–92
  • Tsigos C, Chrousos GP. (2002). Hypothalamic-pituitary-adrenal axis, neuroendocrine factors and stress. J Psychosom Res 53:865–71
  • Van Craenenbroeck K, De Bosscher K, VandenBerghe W, et al. (2005). Role of glucocorticoids in dopamine-related neuropsychiatric disorders. Mol Cell Endocrinol 245:10–22
  • Volkow ND, Wang GJ, Baler RD. (2011). Reward, dopamine and the control of food intake: Implications for obesity. Trends Cogn Sci 15:37–46
  • Wise RA. (2013). Dual roles of dopamine in food and drug seeking: The drive-reward paradox. Biol Psychiatry 73:819–26
  • Wood SJ, Reniers RL, Heinze K. (2013). Neuroimaging findings in the at-risk mental state: A review of recent literature. Can J Psychiatry 58:13–18
  • Yang Y, Sun Y, Zhang Y, et al. (2013). Enduring increases in anxiety-like behavior and rapid nucleus accumbens dopamine signaling in socially isolated rats. Eur J Neurosci 37:1022–31
  • Yorgason JT, Espana RA, Konstantopoulos JK, et al. (2013). Enduring increases in anxiety-like behavior and rapid nucleus accumbens dopamine signaling in socially isolated rats. Eur J Neurosci 37:1022–31
  • Zafir A, Banu N. (2009). Modulation of in vivo oxidative status by exogenous corticosterone and restraint stress in rats. Stress 12:167–77
  • Zalachoras I, Houtman R, Meijer OC. (2013). Understanding stress-effects in the brain via transcriptional signal transduction pathways. Neuroscience 24:97–109

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.